Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
In conclusion, the combination administration of TSAIII and PTX had a significantly therapeutic effect on NPC and avoided the PTX's side effects, which may have acted as a new direction for the study of therapeutic approaches for NPC clinically.PMID:35586672 | PMC:PMC9110172 | DOI:10.1155/2022/6756676
Source: Computational and Mathematical Methods in Medicine - Category: Statistics Authors: Xiaofeng Li Wen Lu Tianjiao Zhou Feng Zhao Li Yang Source Type: research
More News: Cancer & Oncology | Carcinoma | Lymphoma | Nasopharyngeal Cancer | Statistics | Study | Transplants